The frequency of IL-4-producing B cells was reduced in response to IgG from HCs and ATLL patients compared to mock and IVIg conditions (Figure 4B and Supplementary Figure S5). The gene discussed is IL4; the disease is adult T-cell leukemia/lymphoma.